EML4 and non-small cell lung carcinoma: In this study, we evaluated PF-02341066 as a potential radiation-sensitizing agent in 5 different established NSCLC cell lines (H460, A549, H3122, H2228 and H1993) with varying expression levels of c-Met and EML4-ALK (8).